George Noumi
Obstetrics & Gynecology · New York, NYNPI 1215001375
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 31.6% of the total. Reporting peaked in 2021 at $1,109 and has fallen 61.6% since, to $426 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $55.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Myovant Sciences Inc.$463
- Astellas Pharma US Inc$445
- Hologic Sales And Service, LLC$312
- GSK$250
- Aspira Women's Health Inc$229
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,65996%
- Education$1774%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $1,530 |
| Myovant Sciences Inc. | 7 | $463 |
| Astellas Pharma US Inc | 11 | $445 |
| Hologic Sales And Service, LLC | 6 | $312 |
| GSK | 2 | $250 |
| Aspira Women's Health Inc | 4 | $229 |
| Sumitomo Pharma America, Inc. | 7 | $200 |
| Baxter Healthcare | 2 | $175 |
| Evofem Biosciences, Inc. | 3 | $168 |
| Daiichi Sankyo Inc. | 8 | $168 |
| Davol Inc. | 1 | $155 |
| Novo Nordisk | 1 | $125 |
| Agile Therapeutics, Inc. | 1 | $125 |
| Organon | 1 | $123 |
| Channel Medsystems, Inc. | 1 | $76 |
| Biogen | 2 | $48 |
| Mayne Pharma Commercial LLC | 2 | $48 |
| Coopersurgical, Inc. | 2 | $37 |
| Lupin Inc. | 2 | $37 |
| Johnson & Johnson | 1 | $28 |
| Shield Therapeutics Inc | 1 | $27 |
| Avion Pharmaceuticals | 1 | $19 |
| Mission Pharmacal Company | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$854
- MYFEMBREE$375
- ORIAHNN$270
- STARLING SYSTEM$144
- OMNI HYSTEROSCOPE$141
- NovaSure$141
- ACESSA PROVU SYSTEM$141
- Veozah$140
- SHINGRIX$125
- AREXVY$125
- Wegovy$125
- Twirla$125
- Phexxi$124
- JADA SYSTEM$123
- OVA1$109
How this compares
$4,836 in reported general payments places this provider in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terconazole | 22 | $501 |
| ValacyclovirValacyclovir Hcl | 23 | $353 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
- Melanie MarinNew York$123K
- Amitasrigowri MurthyNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.